Loading...

ONCOTELIC THERAPEUTICS INC Investor Conferences 8-K Filing

NCTL

ONCOTELIC THERAPEUTICS INC

()

2025 8-K

Joint Development Agreement

Product Launch Announcement

Research Presentation

Financing Agreement

Stock Agreement Details

Milestone Amendment

Contract Amendment

Funding Agreement Completed

Debt Financing Agreement

Access to Research Tools

Investment Offering Details

Investor Presentation Update

Equity Offerings

Presentation Announcement

External Links:

On October 21, 2025, Oncotelic Therapeutics, Inc. announced that CEO Dr. Vuong Trieu presented an investor corporate presentation at LD Micro in San Diego, California, sharing insights on future plans and developments for the company.

AI Assistant

ONCOTELIC THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.